Novocure Ltd (NVCR) earnings · rev $655.4M
These earnings events as JSON? API free 100/dayNovocure Ltd (NVCR) is a medical devices company listed on US.
This NVCR earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported NVCR revenue for 2025-12-31 was $655.4M. Net income was -$136.2M. Revenue was up 400.3% from 2022-09-30 to 2025-12-31. NVCR currently screens at market cap $1.99B.
When the next NVCR 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 400.3% from 2022-09-30 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full NVCR research stays on the stock page; the tape stays on the quote page.
NVCR earnings FAQ
What are NVCR's latest revenue and net income?
Latest cached Novocure Ltd (NVCR) revenue for Dec 31, 2025 was $655.4M. Net income was -$136.2M. Statements: https://lician.com/financials/nvcr
What is NVCR's latest diluted EPS?
Latest cached Novocure Ltd (NVCR) diluted EPS for Dec 31, 2025 was -$1.22.
What period does the latest NVCR earnings print cover?
The latest cached Novocure Ltd (NVCR) earnings print covers Dec 31, 2025. The prior cached period on this page is Sep 30, 2022.
How did NVCR revenue change from the prior cached period?
Cached Novocure Ltd (NVCR) revenue was up 400.3% from $131.0M (Sep 30, 2022) to $655.4M (Dec 31, 2025). Statements: https://lician.com/financials/nvcr
Where are NVCR earnings listed?
Cached earnings facts for Novocure Ltd (NVCR) are listed at https://lician.com/earnings/nvcr. Statements: https://lician.com/financials/nvcr
Not investment advice.